MCK:NYSE
McKesson Corp
$889.12
arrow_downward
-0.00%(-0.020) 1D
Sep 8, 4:00:06 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MCK...
Mkt. cap
103.66B
Avg. vol.
997.50K
Volume
238.00
Dividend
0.42%
Quarterly dividend
$0.94
Ex-dividend date
Sep 1, 2026
P/E ratio
23.81
52-wk high
$999.00
52-wk low
$687.68
EPS
$37.35
Beta
0.30
Shares outstanding
116.59M
No. of employees
42K
Mkt. cap
103.66B
Avg. vol.
997.50K
Volume
238.00
Dividend
0.42%
Quarterly dividend
$0.94
Ex-dividend date
Sep 1, 2026
P/E ratio
23.81
52-wk high
$999.00
52-wk low
$687.68
EPS
$37.35
Beta
0.30
Shares outstanding
116.59M
No. of employees
42K
News stories
From web sources and news partners
Simply Wall Street
·
1 hour ago
McKesson (MCK) Stock Still Looks Reasonable Following Third Party Cyberattack
AD HOC NEWS
·
17 hours ago
McKesson stock highlights oncology push and Q1 growth at Wells Fargo conference
Investing.com
·
23 hours ago
McKesson at wells fargo healthcare conference: growth, deal push
Yahoo Finance
·
2 days ago
McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy
Profile
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
About McKesson Corp
CEOBrian S. Tyler
Employees42.3K
Founded1835
Headquarters-
SectorHealth care provider
Websitemckesson.com